Eylea recommended for approval in Europe for DME visual impairment

Aflibercept injection has been recommended for approval by the European Committee for Medicinal Products for Human Use for the treatment of visual impairment due to diabetic macular edema, according to a Regeneron press release.The recommendation is based on positive data from the phase 3 VIVID-DME and VISTA-DME studies.

Full Story →